Population
In vitro model using Escherichia coli expressing hepatitis C virus nonstructural protein 3 polypeptide and…
Design
Preclinical
Authors
Loading...
Does not alter HCV management; extends NS3 helicase characterization to guide future antiviral design.
HCV NS3 exhibits unique 3' to 5' RNA and DNA helicase activity that is dependent on the polarity of the bound RNA strand.
Tai et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: